In five trials (35 192parthereants), there was high-quality evidence of increased vomiting (RR 1.29 (1.14 to 1.46)).
Four years later, she developed, over a week increased vomiting and headaches.
Oral PGE2 was associated with increased vomiting compared to IV oxytocin (3 studies, 305 women, 25/150 versus 4/155; RR 5.56, 95% CI 2.15 to14.38; NNH = 9).
This results in headaches of increasing intensity, vomiting, dizziness, confusion, pupils of unequal size, weakness on one side of the body, increased blood pressure and, if left untreated, seizures and death.
Although not strongly hazardous, it can cause some harmful effects in humans such as heartbeat increase, vomiting, shock, cyanosis, jaundice, quadriplegia, and tissue necrosis.
Although it has low toxicity, it can cause some specific harmful effects for the human health such as heartbeat increase, vomiting, shocks, cyanosis, jaundice and tissue necrosis [11, 12].
Clinical effects include severe irritation and pain to eyes, mouth, nose and throat, cardiovascular and respiratory symptoms, paralysis and seizures, increased salivation, vomiting, hyperkalemia, cyanosis and hallucinations.
Summary: Oral prostaglandins are associated with increased maternal vomiting and diarrhea compared with IV oxytocin.
The many factors that contribute to malnutrition such as weight loss, decreased intake, absorption, or digestion and increased diarrhea, vomiting, or steatorrhea are present in patients with intestinal PRD leading to the assumption that malnutrition is present.
